Overview of the clinical efficacy and safety of eldecalcitol for the treatment of osteoporosis

被引:0
作者
Lijia Cui
Weibo Xia
Chuan Yu
Shuangshuang Dong
Yu Pei
机构
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Endocrinology, Peking Union Medical College Hospital
[2] Chugai Pharma China CO.,Department of Endocrinology, First Medical Center
[3] LTD,undefined
[4] General Hospital of the People’s Liberation Army of China,undefined
来源
Archives of Osteoporosis | 2022年 / 17卷
关键词
Eldecalcitol; Bone mineral density; Osteoporosis; Fracture; Systematic review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 75 条
[1]  
Reymondier A(2013)MENOPOST–calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study Osteoporosis Int 24 559-566
[2]  
Caillet P(2017)Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study Osteoporosis Int 28 1903-1913
[3]  
Abbas-Chorfa F(1995)Structure-function relationships in the vitamin D endocrine system Endocrine Rev 16 200-257
[4]  
Tamaki J(2016)Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials Drug Des Devel Ther 10 509-517
[5]  
Iki M(2013)Eldecalcitol for the treatment of osteoporosis Clin Interv Aging 8 1313-1321
[6]  
Sato Y(2011)Eldecalcitol. a review of its use in the treatment of osteoporosis Drugs 71 1755-1770
[7]  
Bouillon R(2012)Spotlight on eldecalcitol in osteoporosis Drugs Aging 29 69-71
[8]  
Okamura WH(2013)Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses PLoS ONE 8 e83138-1607
[9]  
Norman AW(2019)Comparison of the efficacy and safety of remifentanil versus different pharmacological approaches on prevention of etomidate-induced myoclonus: a meta-analysis of randomized controlled trials Drug Des Dev Ther 13 1593-654
[10]  
Xu Z(2005)The interpretation of random-effects metaanalysis in decision models Med Decis Making 25 646-560